During the past decade, Retina Vitreous Medical Group Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Retina Vitreous Medical Group Clinical Research" are "Diabetic Macular Edema" (1 trials), "Macular Edema" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Retina Vitreous Medical Group Clinical Research" in a lesser frequency.

Most popular intervention types in "Retina Vitreous Medical Group Clinical Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "IVT aflibercept" (2 trials), "SC CLS-TA" (1 trials), "Sham SC" (1 trials), "suprachoroidal CLS-TA" (1 trials) and "suprachoroidal sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Vitreous Medical Group Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Retina Vitreous Medical Group Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Retina Vitreous Medical Group Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Vitreous Medical Group Clinical Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".